Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Broderick, Gordon ^a   Katz, Ben Z ^b   Fernandes, Henrique ^a   Fletcher, Mary A ^c   Klimas, Nancy ^d   Smith, Frederick A ^e   O'Gorman, Maurice R G ^b,e   Vernon, Suzanne D ^f   Taylor, Renee ^g  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f CFIDS Association of America   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chronic fatigue; Classification model; Cytokines; Infectious mononucleosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHEMOLUMINESCENCE; CHRONIC FATIGUE SYNDROME; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INCIDENCE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TH17 CELL;

ADOLESCENT; COHORT STUDIES; CYTOKINES; FATIGUE; GENE EXPRESSION PROFILING; HUMANS; INFECTIOUS MONONUCLEOSIS;

EID: 84866064369     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-191     Document Type: Article

References (53)

1. Chandler HK, Ciccone D, MacBride RJ, Natelson B. Medically unexplained illness in short- and long-term disability applicants: prevalence and cost of salary reimbursement. Disabil Rehabil 2008, 30(16):1185-1191. 10.1080/09638280701500109, 17852256.
2. Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, Boneva RS, Morrissey M, Devlin R. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul. Health Metr. 2007, 5:5. 10.1186/1478-7954-5-5, 1904178, 17559660.
3. Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff. Resour. Alloc. 2004, 2(1):4. 10.1186/1478-7547-2-4, 449736, 15210053.
4. Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME/CFS: Individual and societal costs. Dyn. Med. 2008, 7:6. 10.1186/1476-5918-7-6, 2324078, 18397528.
5. Leake JP, Cedar ET, Dearing WP, Gilliam AG, Chope HD. Epidemiology of Poliomyelitis in California, 1934. Am J Public Health Nations Health 1934, 24(12):1204-1206. 10.2105/AJPH.24.12.1204, 1558957, 18014089.
6. Sigurdsson B, Sigurjonsson J, Sigurdsson JH, Thorkelsson J, Gudmundsson KR. A disease epidemic in Iceland simulating poliomyelitis. Am J Hyg 1950, 52(2):222-238.
7. Sigurdsson B. Clinical findings six years after outbreak of Akureyri disease. Lancet 1956, 270(6926):766-767.
8. Bell DS, Jordan K, Robinson M. Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome. Pediatrics 2001, 107(5):994-998. 10.1542/peds.107.5.994, 11331676.
9. Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?. J.A.M.A 1987, 257(17):2297-2302. 10.1001/jama.1987.03390170053027, 3033337.
10. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Brown N, Schooley RT, Brus I. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988, 108(3):387-389.
11. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, Clare AW. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 1998, 173:475-481. 10.1192/bjp.173.6.475, 9926075.
12. Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med 2000, 109:531-537. 10.1016/S0002-9343(00)00560-X, 11063953.
13. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A, . Dubbo Infection Outcomes Study Group Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. B.M.J 2006, 333(7568):575. Dubbo Infection Outcomes Study Group.
14. Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics 2009, 124(1):189-193. 10.1542/peds.2008-1879, 2756827, 19564299.
15. Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol 2010, 63(2):165-168. 10.1136/jcp.2009.070466, 19828908.
16. Seishima M, Mizutani Y, Shibuya Y, Arakawa C. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia. Dermatology 2008, 216(4):341-346. 10.1159/000116723, 18277075.
17. Kerr JR, Bracewell J, Laing I, Mattey DL, Bernstein RM, Bruce IN, Tyrrell DA. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol 2002, 29(3):595-602.
18. Zhang L, Gough J, Christmas D, Mattey DL, Richards SC, Main J, Enlander D, Honeybourne D, Ayres JG, Nutt DJ, Kerr JR. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol 2010, 63(2):156-164. 10.1136/jcp.2009.072561, 2921262, 19955554.
19. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The Chronic Fatigue Syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994, 121:953-959.
20. Reeves WC, Lloyd A, Vernon SD, Klimas NG, Jason LA, Bleijenberg G, Evengard B, White PD, Nisenbaum R, Unger ER, . International Chronic Fatigue Syndrome Study Group Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003, 3(1):25. 10.1186/1472-6963-3-25, 317472, 14702202, International Chronic Fatigue Syndrome Study Group.
21. Huang Y, Katz BZ, Mears C, Kielhofner GW, Taylor R. Postinfectious fatigue in adolescents and physical activity. Arch Pediatr Adolesc Med 2010, 164(9):803-809. 10.1001/archpediatrics.2010.144, 3050621, 20819961.
22. Katz BZ, Boas S, Shiraishi Y, Mears CJ, Taylor R. Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis. J Pediatr 2010, 157(3):468-472. 10.1016/j.jpeds.2010.03.025, 2975670, 20447647.
23. Taylor R, O'Brien J, Kielhofner GW, Lee S-W, Katz BZ, Mears CJ. The occupational and quality of life consequences of chronic fatigue syndrome/myalgic encephalomyelitis in young people. Brit. J. Occ. Therapy 2010, 73:524-530.
24. Katz BZ, Stewart JM, Shiraishi Y, Mears CJ, Taylor R. Autonomic symptoms at baseline and following infectious mononucleosis in a prospective cohort of adolescents. Arch. Pediatr. Adol. Med. 2011, 165:765-766.
25. Maher K, Klimas NG, Fletcher MA. Immunology. Handbook of Chronic Fatigues 2003, 124-151. John Wiley & Sons, Hoboken, Jason LA, Fennell PA, Taylor RR.
26. Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med 2009, 7:96. 10.1186/1479-5876-7-96, 2779802, 19909538.
27. Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010, 24(7):1209-1217. 10.1016/j.bbi.2010.04.012, 2939140, 20447453.
28. Vollmer-Conna U, Cameron B, Hadzi-Pavlovic D, Singletary K, Davenport T, Vernon SD, Reeves WC, Hickie I, Wakefield D, Lloyd AR, . Dubbo Infective Outcomes Study Group Postinfective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis 2007, 45(6):732-735. 10.1086/520990, 17712757, Dubbo Infective Outcomes Study Group.
29. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999, 159(18):2129-2137. 10.1001/archinte.159.18.2129, 10527290.
30. Jason LA, Jordan K, Miike T, Bell DS, Lapp C, Torres-Harding S, Rowe K, Gurwitt A, DeMerlier K, Van Hoof E. A pediatric case definition for myalgic encephalomyelitis and chronic fatigue syndrome. J. Chronic Fatigue Syndrome 2006, 13:1-44.
31. Chalder T, Berelowitz C, Pawlikowska T. Development of a fatigue scale. J Psychosom Res 1993, 37:147-154. 10.1016/0022-3999(93)90081-P, 8463991.
32. Rawlings JO. Collinearity Diagnostics. Applied Regression Analysis 1988, 273-281. Wadsworth and Brooks, Pacific Grove, Barndorff-Nielsen OE, Bickel PJ, Cleveland WS, Dudley RM.
33. Draper NR, Smith H. Stepwise Regression. Applied Regression Analysis 1998, 307-312. NJ: Wiley-Interscience, Hoboken.
34. Pizzichini MM, Pizzichini E, Efthimiadis A, Chauhan AJ, Johnston SL, Hussack P, Mahony J, Dolovich J, Hargreave FE. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998, 158(4):1178-1184.
35. Chanan-Khan AA, Chitta K, Ersing N, Paulus A, Masood A, Sher T, Swaika A, Wallace PK, Mashtare TL, Wilding G, Lee K, Czuczman MS, Borrello I, Bangia N. Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response. Br J Haematol 2011, 155(4):457-467. 10.1111/j.1365-2141.2011.08882.x, 22010965.
36. Torchinsky MB, Blander JM. T helper 17 cells: discovery, function, and physiological trigger. Cell Mol Life Sci 2010, 67(9):1407-1421. 10.1007/s00018-009-0248-3, 20054607.
37. Ma XT, Zhang XJ, Zhang B, Geng YQ, Lin YM, Li G, Wu KF. Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers. Cell Biol Int 2004, 28(10):689-697. 10.1016/j.cellbi.2004.07.002, 15516327.
38. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O'shea JJ. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26(3):371-381. 10.1016/j.immuni.2007.02.009, 17363300.
39. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008, 223:87-113. 10.1111/j.1600-065X.2008.00628.x, 3299089, 18613831.
40. Liu FL, Chen CH, Chu SJ, Chen JH, Lai JH, Sytwu HK, Chang DM. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology (Oxford) 2007, 46(8):1266-1273.
41. Casiraghi C, Shanina I, Cho S, Freeman ML, Blackman MA, Horwitz M. Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis. PLoS Pathog 2012, 8(5):e1002715. 10.1371/journal.ppat.1002715, 3355105, 22615572.
42. Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, Carl JW, Yu C, Shi FD, Whitacre CC, Trgovcich J, Bai XF. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 2012, 188(7):3099-3106. 10.4049/jimmunol.1100106, 22387555.
43. Fiola S, Gosselin D, Takada K, Gosselin J. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J Immunol 2010, 185(6):3620-3631. 10.4049/jimmunol.0903736, 20713890.
44. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med 2011, 9:81. 10.1186/1479-5876-9-81, 3120691, 21619669.
45. Amel Kashipaz MR, Swinden D, Todd I, Powell RJ. Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol 2003, 132(2):360-365. 10.1046/j.1365-2249.2003.02149.x, 1808704, 12699429.
46. Skowera A, Cleare A, Blair D, Bevis L, Wessely SC, Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 2004, 135(2):294-302. 10.1111/j.1365-2249.2004.02354.x, 1808936, 14738459.
47. Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res 1997, 31(1):59-65. 10.1016/S0022-3956(96)00050-7, 9201648.
48. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006, 367(9507):346-355. Review, 10.1016/S0140-6736(06)68073-2, 16443043.
49. Smith MS, Mitchell J, Corey L, Gold D, McCauley EA, Glover D, Tenover FC. Chronic fatigue in adolescents. Pediatrics 1991, 88(2):195-202.
50. Feder HM, Dworkin PH, Orkin C. Outcome of 48 pediatric patients with chronic fatigue. A clinical experience. Arch Fam Med 1994, 3(12):1049-1055. 10.1001/archfami.3.12.1049, 7804489.
51. Carter BD, Edwards JF, Kronenberger WG, Michalczyk L, Marshall GS. Case control study of chronic fatigue in pediatric patients. Pediatrics 1995, 95(2):179-186.
52. Krilov LR, Fisher M, Friedman SB, Reitman D, Mandel FS. Course and outcome of chronic fatigue in children and adolescents. Pediatrics 1998, 102(2 Pt 1):360-366.
53. Sankey A, Hill CM, Brown J, Quinn L, Fletcher MA. A follow-up study of chronic fatigue syndrome in children and adolescents: symptom persistence and school absenteeism. Clin Child Psychol Psychiatry 2006, 11(1):126-138. 10.1177/1359104506059133, 17087490.